A new retrospective observational study from the London Women’s Clinic offers unprecedented data on how transgender and non-binary people in the UK are accessing assisted reproductive technologies (ART). Conducted over 14 years, the report documents the experiences of 64 individuals who identified as trans or non-binary, or who had a trans+ partner, and who sought either to preserve their fertility or to begin a family.
The study, titled “Fertility preservation and family making in transgender and non-binary patients in the UK; fourteen years of family formation at a UK-licensed centre,” fills a long-standing research gap and provides both clinical and social insight into reproductive decision-making within this under-represented population.
Key Findings: Assisted Reproduction Is Working for Trans+ Patients
One of the most significant findings is that trans+ patients are successfully utilising the full spectrum of assisted reproduction options available in the UK. These methods include the use of donor gametes, intrauterine insemination (IUI), in vitro fertilisation (IVF), and, in some cases, surrogacy. Among these, IVF showed notably higher success rates when compared to IUI. The report reinforces that, when medical care is inclusive and legally informed, family formation for trans+ people is not only possible but effective.
Dr. Kamal Ahuja, Scientific and Managing Director at London Women’s Clinic, emphasises that the study can serve as a reference point for both clinicians and patients. He explains that the documented cases provide real-world examples that may encourage some trans+ individuals to pursue parenthood, while helping others decide whether the process aligns with their needs and circumstances. Crucially, he highlights that the legal clarity surrounding assisted reproduction in the UK has played a key role in avoiding disputes or complications.
Legal Framework and Emotional Barriers
For many trans+ people, the decision to pursue fertility treatment is complicated by medical, emotional, and legal concerns. Fertility can be impacted by gender-affirming treatments, and the lack of visibility around successful outcomes often fuels the fear that biological parenthood is unattainable. As Dr. Ahuja notes, the UK’s clearly defined legal structures protect both patients and service providers, preventing the custody and parental-status disputes that may arise in countries without such frameworks. Over the entire 14-year dataset, no legal complications occurred—a finding the clinic considers highly significant.
Egg Freezing as a Milestone for Trans Men and Non-Binary People
The report also spotlights egg freezing as a critical development for those who may wish to transition medically while still retaining the option of having genetically related children. Dr. Ahuja calls egg freezing “one of the most dramatic developments in assisted reproduction,” noting that both technology and social understanding have evolved in ways that now support diverse family structures. He hopes the study will further shift attitudes and encourage healthcare systems to adopt more inclusive fertility counselling.
A Future Built on Evidence, Not Assumptions
Historically, trans+ people have been excluded from reproductive research, resulting in limited guidance and inconsistent care. This report represents a turning point: it provides data-driven evidence that trans+ family-building is both realistic and already happening. For patients, it offers reassurance and informed choice. For clinicians, it offers a model of care rooted in ethics, legality, and lived experience.
Related topics
